PMID: 2497168May 1, 1989Paper

Theophylline does not inhibit allergen-induced increase in airway responsiveness to methacholine

The Journal of Allergy and Clinical Immunology
D W CockcroftP Manning

Abstract

Allergen-induced increase in airway hyperresponsiveness can be used as a model of airway inflammation for assessing antiasthma pharmacologic agents. Steroids and cromolyn, but not beta-agonists, inhibit this increase; theophylline, recently suggested as having anti-inflammatory effects, has not been evaluated in this model. Six atopic subjects with asthma and with late asthmatic responses (N = 5) and postallergen reduction in a provocative concentration of methacholine causing a 20% fall in FEV1 (PC20) (N = 6) were studied. Sustained-release theophylline (Theo-Dur; Astra Pharmaceuticals Canada, Ltd., Mississauga, Canada), 300 mg, and placebo were administered single-blind twice daily for eight doses up to 1 hour before allergen inhalation; cromolyn sodium, 10 mg, was administered in a single dose 10 minutes before allergen inhalation on another day as a "positive control." Mean theophylline levels were in the low therapeutic range, 57 +/- 17 and 58 +/- 13 mumol/L 1 and 8 hours after the last tablet. The FEV1 was 7% and 9% greater after the seventh and eighth doses of theophylline versus placebo (p less than 0.05). Theophylline also produced a significant (p less than 0.05) twofold increase in methacholine PC20. There was a 40% ...Continue Reading

Citations

Aug 1, 1996·The Journal of Allergy and Clinical Immunology·M KraftR J Martin
Nov 30, 1989·The New England Journal of Medicine·P J Barnes
Jun 4, 1992·The New England Journal of Medicine·G L Larsen
Dec 12, 2002·Current Opinion in Pulmonary Medicine·Domenico Spina
May 1, 1997·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·A M BentleyS R Durham
Oct 1, 1992·Journal of Clinical Pharmacy and Therapeutics·H W Kelly
Dec 1, 1990·Clinical and Experimental Pharmacology & Physiology·M KanekoT Satake
Aug 26, 1998·Thorax·J LötvallP O'Byrne
Mar 1, 1993·The American Review of Respiratory Disease·A J WardJ F Costello
Mar 20, 2001·Pharmacotherapy·K V Blake
Jan 1, 1991·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·S R Durham
May 1, 1991·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·H MagnussenD Nowak
Mar 1, 1996·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·K F Chung
Mar 1, 1996·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·S Makino
Jan 1, 1995·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·M B Emanuel, P H Howarth
Jan 25, 2006·British Journal of Pharmacology·Sandra KeirClive Page
Sep 12, 2007·Allergy·L-P BouletUNKNOWN Clinical Investigative Collaboration, Canadian Network of Centers of Excellence AllerGen
Feb 4, 2009·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·P M O'ByrneJ D Brannan
Apr 1, 1990·The Journal of Allergy and Clinical Immunology·D G TinkelmanC N Lutz
May 1, 1991·The Journal of Allergy and Clinical Immunology·D W Cockcroft
Jul 7, 2000·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·P M O'Byrne, M D Inman
Aug 1, 1996·Respiratory Medicine·S T Holgate
Apr 14, 2012·Current Opinion in Pharmacology·Clive P Page, Domenico Spina
Oct 8, 2005·The Journal of Allergy and Clinical Immunology·Beth E DavisDonald W Cockcroft
Jan 1, 1990·Respiratory Medicine·C J Trigg, R J Davies
Jan 1, 1993·Journal of Learning Disabilities·M P Celano, R J Geller
Mar 13, 2010·Allergy, Asthma & Immunology Research·Paul M O'Byrne
Sep 1, 1991·DICP : the Annals of Pharmacotherapy·M R Hill, A K Kamada
Jan 15, 1990·Hospital Practice·D W Cockcroft
Jul 1, 1993·The Annals of Pharmacotherapy·J S Larsen, E P Acosta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.